Search Results
7/10/2025, 3:13:42 PM
>>510006686
https://arstechnica.com/tech-policy/2018/04/curing-disease-not-a-sustainable-business-model-goldman-sachs-analysts-say/
There are in fact theories that the genetic damage done by these vaccines, was a way of getting Big Pharma's foot into the door of everyone's genomes, and get them on gene therapies for the ultimate sustainable business model.
https://arstechnica.com/tech-policy/2018/04/curing-disease-not-a-sustainable-business-model-goldman-sachs-analysts-say/
There are in fact theories that the genetic damage done by these vaccines, was a way of getting Big Pharma's foot into the door of everyone's genomes, and get them on gene therapies for the ultimate sustainable business model.
Page 1